Эстония - эстонский - Ravimiamet

gp-pharm s.a. - oktreotiid - süstelahus - 100mcg 1ml 1ml 5tk

Эстония - эстонский - Ravimiamet

gp-pharm s.a. - oktreotiid - süstelahus - 50mcg 1ml 1ml 5tk

Эстония - эстонский - Ravimiamet

gp-pharm s.a. - oktreotiid - süstelahus - 500mcg 1ml 1ml 5tk

Европейский союз - эстонский - EMA (European Medicines Agency)

eli lilly nederland b.v. - glucagon - diabeet mellitus - pankrease hormoonid, hormoonid glycogenolytic - baqsimi on näidustatud ravi raskeid hypoglycaemia täiskasvanutel, noorukitel ja lastel vanuses 4 aastat ja enam, kellel diabeet.

Европейский союз - эстонский - EMA (European Medicines Agency)

eli lilly nederland b.v. - tirzepatide - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 ja 5.

Эстония - эстонский - Ravimiamet

bioveta a.s. - küülikute müksomatoosi elusviirusvaktsiin - süstesuspensiooni lüofilisaat ja lahusti - 10000tcid50 1annus 1annus 5tk; 10000tcid50 1annus 1annus 10tk; 10000tcid50 1annus 10annus 1tk; 10000tcid50 1annus 1annus 1tk; 10000tcid50 1annus 40annus 1tk; 10000tcid50 1annus 100annus 1tk; 10000tcid50 1annus 50annus 1tk; 10000tcid50 1annus 50annus 5tk; 10000tcid50 1annus 40annus 5tk; 10000tcid50 1annus 100annus 5tk; 10000tcid50 1annus 10annus 5tk; 10000tcid50 1annus 80annus 5tk; 10000tcid50 1annus 80annus 1tk

Эстония - эстонский - Ravimiamet

novartis baltics sia - oktreotiid - süste-/infusioonilahus - 0,1mg 1ml 1ml 10tk; 0,1mg 1ml 1ml 6tk; 0,1mg 1ml 1ml 3tk; 0,1mg 1ml 1ml 20tk; 0,1mg 1ml 1ml 5tk

Европейский союз - эстонский - EMA (European Medicines Agency)

novo nordisk a/s - iniminsuliin - diabeet mellitus - diabeetis kasutatavad ravimid - suhkurtõve ravi.

Европейский союз - эстонский - EMA (European Medicines Agency)

novartis europharm limited - vildagliptiin - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Европейский союз - эстонский - EMA (European Medicines Agency)

novartis europharm limited - vildagliptiin - suhkurtõbi, tüüp 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).